VEEVVeeva Systems

$244.97
Veeva Systems logo

Price

$244.97-13%1Y
1M+36%1Y-13%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value62
Quality86
Momentum29
Growth65
Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions—from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations.

In the company’s own words · 10-K filed Mar 20, 2026 · SEC EDGAR

P/E (TTM)43.4
Market Cap$24.90B
1Y Return-13%
5Y Return-26%

Business segments

Q2 2026 · $882.9M

The company’s own SEC segment disclosure.

  • Subscription Services Veeva Research And Development And Quality Solutions$392.3M44%
  • Subscription Services Veeva Commercial Cloud$337.9M38%
  • Professional Services Veeva Research And Development And Quality Solutions$95.2M11%
  • Professional Services Veeva Commercial Cloud$57.6M7%

Veeva Systems (VEEV) reported revenue of $883M in Q1 2027 (quarter ended April 30, 2026), up 16% from the same quarter a year earlier. That came with a gross margin of 75% and net income of $261M (30% of revenue). For the full year FY2026, revenue was $3.20B (+16% year on year) and net income $909M. Its largest product in 2026-Q2 was Subscription Services Veeva Research And Development And Quality Solutions at $392M, 44% of the disclosed total, just ahead of Subscription Services Veeva Commercial Cloud at 38%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.